The global inhalation toxicology testing services market is forecast to surge from $14.64 billion in 2025 to an impressive $25.09 billion by 2034, advancing at a strong CAGR of 6.17% over the period. This growth is powered by rapid advancements in alternative testing methods, large-scale government funding, and the relentless drive for regulatory compliance in […]
Sperm Cryopreservation Market Companies Cryo-Save AG Fairfax Cryobank New England Cryogenic Center, Inc. European Sperm Bank California Cryobank Androcryos London Sperm Bank ReproTech, Ltd. Xytex Corporation Seattle Sperm Bank Indian Spermtech Nordic Cryobank Manhattan Cryobank Cryos International Legacy (Fertility Preservation Startup) Genea Biomedx Vivere-Gestión Reproductive Medicine Associates (RMA) Network Monash IVF Group Boston IVF Get
Renal Denervation Devices Market Companies Ablative Solutions, Inc. Abbott Avinger/related interventional companies Boston Scientific Corporation Kona Medical, Inc Mercator MedSystems, Inc Medtronic plc Neuravi/Renal-focused interventional firms PulseCath Technologies/investigational device firms ReCor Medical, Inc. Renal Dynamics Limited SoniVie/CardioSonic(historical ultrasound/early programs) Symple Surgical, Inc. Terumo Corporation Vascular/specialty device firms offering RDN-capable platforms Get Sample Report Ablative Solutions,
Estrogen Replacement Therapy Market Companies Pfizer Inc. Bayer AG Novartis AG Merck & Co., Inc. Abbott Laboratories Novo Nordisk A/S Eli Lilly and Company Teva Pharmaceutical Industries Ltd. Mylan N.V. (Viatris Inc.) Endo International plc. TherapeuticsMD, Inc. Allergan plc. (AbbVie Inc.) Amgen Inc. Ipsen Biopharmaceuticals Orion Pharma Ferring Pharmaceuticals Aspen Pharmacare Holdings Limited Sun Pharmaceutical
Advanced Monitoring Tech to Transform Home Healthcare and Digital Wellness Globally The global next generation pulse oximeters market is expected to reach unprecedented heights between 2025 and 2034, driven by an expanding focus on telemedicine, preventive care, and digital health ecosystems. With a robust CAGR forecast and North America claiming the top spot for innovation,
Neurological Rare Disease Biologics Market Companies Alexion (AstraZeneca) Amgen Biogen Bluebird bio Catalent Eli Lilly Ionis Pharmaceuticals Novartis Pfizer Regenxbio Roche / Genentech Sanofi Sarepta Therapeutics Stoke Therapeutics UCB Get Sample Report 1. Alexion (AstraZeneca) Company Name and Headquarters: Alexion Pharmaceuticals, Inc. (an AstraZeneca Company), headquartered in Boston, Massachusetts, USA. Product Offerings related to Neurological Rare Disease
Peptide Therapeutics CDMO Market Companies Almac Group AmbioPharm Inc. American Peptide Company Auspep Pty Ltd. Bachem AG BCN Peptides S.A. Chinese Peptide Company (CPC) CordenPharma International CPC Scientific Inc. Creative Peptides CSBio Co. GenScript Biotech Corporation Lonza Group Ltd. Peptide Institute Inc. Piramal Pharma Solutions PolyPeptide Group Sanofi (Zentiva) ScinoPharm Taiwan Ltd. Siegfried Holding AG
AI-Integrated CDMO Process Optimization Market Companies Lonza Group Ltd. Catalent Inc. Thermo Fisher Scientific Inc. LabCorp Drug Development IQVIA Technologies WuXi AppTec Co. Ltd. Boehringer Ingelheim Samsung Biologics Recipharm AB Patheon (part of Thermo Fisher) Evonik Industries AG Siegfried Holding AG Aenova Group Cambrex Corporation Albany Molecular Research Inc. (AMRI) Piramal Pharma Solutions Metrics Contract
Health Information Exchange (HIE) Market Companies Cerner Corporation Allscripts Healthcare Solutions, Inc. McKesson Corporation GE Healthcare Meditech eClinicalWorks NextGen Healthcare Orion Health InterSystems Corporation Optum, Inc. IBM Corporation Siemens Healthineers Athenahealth, Inc. Health Catalyst, Inc. CPSI Oracle Corporation Infor Philips Healthcare HealthFusion SAP SE Get Sample Report Cerner Corporation (Acquired by Oracle) Company Name and Headquarters: Cerner
The global smart retinal implants market is poised for robust expansion from 2025 to 2034, driven by increasing prevalence of vision-impairing diseases, rapid technological advancements in retinal prosthetics, and wider adoption of AI-enabled vision restoration systems. Valued at growing billions today, the market offers new hope for patients suffering from degenerative retinal conditions like age-related
